The 2024 CPHI North America is the only pharma event in the Americas region to cover the end-to-end supply chain with exhibitors from CRO and clinical trials, to manufacturing, packaging, and finished products.
BGL Managing Director Christoph Brandenberger will be attending this year’s conference and available to discuss the state of the healthcare market as well as upcoming opportunities.
BGL’s Diagnostics, Research Tools & Medical Devices investment banking team has decades of experience advising companies across the diagnostics and device landscape. With this in-depth knowledge and background, we have provided M&A and capital markets strategies for a wide range of companies in this sector.